[HTML][HTML] Molecules that target nucleophosmin for cancer treatment: an update
A Di Matteo, M Franceschini, S Chiarella, S Rocchio… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Nucleophosmin is a highly and ubiquitously expressed protein, mainly localized in nucleoli
but able to shuttle between nucleus and cytoplasm. Nucleophosmin plays crucial roles in …
but able to shuttle between nucleus and cytoplasm. Nucleophosmin plays crucial roles in …
Metal–peptide complexes as promising antibiotics to fight emerging drug resistance: New perspectives in tuberculosis
C Di Natale, I De Benedictis, A De Benedictis… - Antibiotics, 2020 - mdpi.com
In metal-peptide interactions, cations form stable complexes through bonds with
coordinating groups as side chains of amino acids. These compounds, among other things …
coordinating groups as side chains of amino acids. These compounds, among other things …
Multistep Inhibition of α-Synuclein Aggregation and Toxicity in Vitro and in Vivo by Trodusquemine
The aggregation of α-synuclein, an intrinsically disordered protein that is highly abundant in
neurons, is closely associated with the onset and progression of Parkinson's disease. We …
neurons, is closely associated with the onset and progression of Parkinson's disease. We …
Trodusquemine displaces protein misfolded oligomers from cell membranes and abrogates their cytotoxicity through a generic mechanism
The onset and progression of numerous protein misfolding diseases are associated with the
presence of oligomers formed during the aberrant aggregation of several different proteins …
presence of oligomers formed during the aberrant aggregation of several different proteins …
Glucosyl platinum (II) complexes inhibit aggregation of the C-terminal region of the Aβ peptide
S La Manna, M Leone, I Iacobucci… - Inorganic …, 2022 - ACS Publications
Neurodegenerative diseases are often caused by uncontrolled amyloid aggregation. Hence,
many drug discovery processes are oriented to evaluate new compounds that are able to …
many drug discovery processes are oriented to evaluate new compounds that are able to …
Plant isoquinoline alkaloids as potential neurodrugs: A comparative study of the effects of benzo [c] phenanthridine and berberine-based compounds on β-amyloid …
Herein we present a comparative study of the effects of isoquinoline alkaloids belonging to
benzo [c] phenanthridine and berberine families on β-amyloid aggregation. Results …
benzo [c] phenanthridine and berberine families on β-amyloid aggregation. Results …
A comparative study of the effects of platinum (II) complexes on β-amyloid aggregation: Potential neurodrug applications
SL Manna, D Florio, I Iacobucci, F Napolitano… - International journal of …, 2021 - mdpi.com
Herein the effects of three platinum complexes, namely (SP-4-2)-(2, 2′-bipyridine)
dichloridoplatinum (II), Pt-bpy,(SP-4-2)-dichlorido (1, 10-phenanthroline) platinum (II), Pt …
dichloridoplatinum (II), Pt-bpy,(SP-4-2)-dichlorido (1, 10-phenanthroline) platinum (II), Pt …
Design of biodegradable bi-compartmental microneedles for the stabilization and the controlled release of the labile molecule collagenase for skin healthcare
C Di Natale, D De Rosa, M Profeta… - Journal of Materials …, 2021 - pubs.rsc.org
Proteins are widely explored as therapeutic agents, but some issues remain alive in their
delivery versus target tissues and organs. Especially in the case of water-labile proteins …
delivery versus target tissues and organs. Especially in the case of water-labile proteins …
Evidence of protein binding by a nucleopeptide based on a thyminedecorated L-diaminopropanoic acid through CD and in silico studies
V Roviello, D Musumeci, A Mokhir… - Current Medicinal …, 2021 - ingentaconnect.com
Background: Nucleopeptides are chimeric compounds of biomedical importance carrying
DNA nucleobases anchored to peptide backbones with the ascertained capacity to bind …
DNA nucleobases anchored to peptide backbones with the ascertained capacity to bind …
Structural insights into amyloid structures of the C-terminal region of nucleophosmin 1 in type A mutation of acute myeloid leukemia
C Di Natale, S La Manna, AM Malfitano… - … et Biophysica Acta (BBA …, 2019 - Elsevier
Acute myeloid leukemia (AML) is a clinically and a molecularly heterogeneous disease
characterized by the accumulation of undifferentiated and uncontrolled proliferation of …
characterized by the accumulation of undifferentiated and uncontrolled proliferation of …